Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Community-acquired pneumonia.

Julie Andrews1, Behzad Nadjm, Vanya Gant

  • 1Department of Clinical Microbiology, University College London Hospitals, London, UK.

Current Opinion in Pulmonary Medicine
|April 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of fungal infections in a patient cohort in The Gambia: Identification and characterization of three priority fungal species in patients with symptoms suggestive of TB.

PloS one·2026
Same author

Parent perspectives on guided self-care approaches to ensure timely access to therapy in infants with food allergy.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same author

Ciprofloxacin prophylaxis in allogeneic haematopoietic cell transplantation reduces bacteraemia but increases antimicrobial resistance without improving patient outcomes.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Machine says go, doctor says no: an ecological momentary assessment analysis examining clinicians' perceptions of, and their antibiotic prescribing behaviour when using rapid molecular diagnostic tests in intensive care.

Antimicrobial resistance and infection control·2026
Same author

Replanting the Birthing Trees to support Aboriginal and Torres Strait Islander parents and babies: protocol for developmental evaluation of a comprehensive culturally responsive, trauma-aware, healing-informed, continuity of care(r) model.

Frontiers in public health·2026
Same author

Correction: Cost-effectiveness of rapid, ICU-based, syndromic PCR in hospital-acquired pneumonia: analysis of the INHALE WP3 multi-centre RCT.

Critical care (London, England)·2025
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Community-acquired pneumonia (CAP) is a significant health concern. Diagnostic tools like urinary antigen testing and PCR improve Streptococcus pneumoniae detection, while vaccines offer key prevention strategies.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Critical Care Medicine

Background:

  • Community-acquired pneumonia (CAP) is a leading cause of illness and death.
  • Streptococcus pneumoniae and respiratory syncytial virus are primary pediatric pathogens.
  • Understanding host immune responses is crucial for managing CAP severity.

Purpose of the Study:

  • To review diagnostic advancements for Streptococcus pneumoniae in CAP.
  • To discuss the role of host immune responses in CAP.
  • To evaluate current and future therapeutic and preventive strategies for CAP.

Main Methods:

  • Review of diagnostic techniques including urinary antigen testing and PCR for Streptococcus pneumoniae.
  • Analysis of host immune responses in relation to CAP severity.

Related Experiment Videos

  • Evaluation of preventive measures like the 7-valent pneumococcal vaccine.
  • Assessment of respiratory support options for severe CAP.

    • Main Results:

    • Urinary antigen testing and PCR demonstrate good sensitivity and specificity for diagnosing S. pneumoniae.
    • The 7-valent pneumococcal vaccine is a significant advancement in preventing invasive pneumococcal disease.
    • Therapies modulating host immune responses are largely experimental.
    • Noninvasive and continuous positive pressure ventilation are options for severe CAP requiring further study.

    Conclusions:

    • Effective diagnostic tools and vaccines are vital for managing CAP.
    • Host immune response modulation remains an area for therapeutic development.
    • Adherence to protocols and appropriate respiratory support are critical for severe cases.